{"description":"Documents matching 'please refer section schedule'","count":10000,"total_pages":50,"next_page_url":"https://www.federalregister.gov/api/v1/documents?conditions%5Bterm%5D=please+refer+section+schedule&format=json&page=2","results":[{"title":"Civil Penalties Schedule Update","type":"Rule","abstract":"FMCSA amends the Federal Motor Carrier Safety Regulations (FMCSRs) to remove the reference to rules under the Department of Transportation's \"Procedures for Transportation Workplace Drug and Alcohol Testing Program\" from the civil penalty schedule in the FMCSRs. Instead, the civil penalty schedule will refer solely to the part of the Code of Federal Regulations (CFR) where this program is incorporated into the FMCSRs. Because the rule does not impose any new material requirements or increase compliance obligations, it is issued without prior notice and opportunity for comment, pursuant to the good cause exception in the Administrative Procedure Act (APA).","document_number":"2025-09703","html_url":"https://www.federalregister.gov/documents/2025/05/30/2025-09703/civil-penalties-schedule-update","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-05-30/pdf/2025-09703.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-09703.pdf?1748376909","publication_date":"2025-05-30","agencies":[{"raw_name":"DEPARTMENT OF TRANSPORTATION","name":"Transportation Department","id":492,"url":"https://www.federalregister.gov/agencies/transportation-department","json_url":"https://www.federalregister.gov/api/v1/agencies/492","parent_id":null,"slug":"transportation-department"},{"raw_name":"Federal Motor Carrier Safety Administration","name":"Federal Motor Carrier Safety Administration","id":181,"url":"https://www.federalregister.gov/agencies/federal-motor-carrier-safety-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/181","parent_id":492,"slug":"federal-motor-carrier-safety-administration"}],"excerpts":"regulations of the countries that they operate in, unless an international agreement states otherwise. Drivers and carriers should be aware of the regulatory differences between nations. \n VI. <span class=\"match\">Section</span>-by-<span class=\"match\">Section</span> Analysis \n This <span class=\"match\">section</span>-by-<span class=\"match\">section</span> analysis describes the changes to the regulatory text in numerical order. \n Appendix B to Part 386—Penalty <span class=\"match\">Schedule</span>: Violations and Monetary Penalties \n FMCSA removes the words “part 40 of this title and” from paragraph (a)(1). \n VII. Regulatory Analyses \n A. Executive Order (E.O.) 12866 (Regulatory Planning"},{"title":"Schedules of Controlled Substances: Placement of Tianeptine in Schedule I","type":"Proposed Rule","abstract":"The Drug Enforcement Administration proposes placing the substance tianeptine (7-[(3-chloro-6,11-dihydro-6-methyl-5,5- dioxidodibenzo[c,f][1,2]thiazepin-11-yl)amino]heptanoic acid), including its isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, salts, and salts of isomers, esters, and ethers is possible, in schedule I of the Controlled Substances Act. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle tianeptine.","document_number":"2026-13821","html_url":"https://www.federalregister.gov/documents/2026/07/08/2026-13821/schedules-of-controlled-substances-placement-of-tianeptine-in-schedule-i","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-07-08/pdf/2026-13821.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13821.pdf?1783428319","publication_date":"2026-07-08","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"substantial \n \n evidence of the potential for abuse of tianeptine. As such, DEA hereby proposes to permanently <span class=\"match\">schedule</span> tianeptine as a <span class=\"match\">schedule</span> I controlled substance under the CSA.\n \n Proposed Determination of Appropriate <span class=\"match\">Schedule</span> \n \n The CSA establishes five <span class=\"match\">schedules</span> of controlled substances known as <span class=\"match\">schedules</span> I, II, III, IV, and V. The CSA also outlines the findings required to place a drug or other substance in any particular <span class=\"match\">schedule</span>.\n 10 \n \n After consideration of the analysis and recommendation of the Assistant Secretary for Health of HHS"},{"title":"Schedule of Application Fees","type":"Rule","abstract":"In this document, the Federal Communications Commission (Commission) revises its Schedule of Application Fees to adjust for increases in the Consumer Price Index (CPI).","document_number":"2025-06899","html_url":"https://www.federalregister.gov/documents/2025/04/23/2025-06899/schedule-of-application-fees","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-04-23/pdf/2025-06899.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-06899.pdf?1745325908","publication_date":"2025-04-23","agencies":[{"raw_name":"FEDERAL COMMUNICATIONS COMMISSION","name":"Federal Communications Commission","id":161,"url":"https://www.federalregister.gov/agencies/federal-communications-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/161","parent_id":null,"slug":"federal-communications-commission"}],"excerpts":"increment. In the Order, we make the 2024 CPI adjustment. \n \n 5. In December 2020, pursuant to authority established by the RAY BAUM'S Act, the Commission adopted a new application fee <span class=\"match\">schedule</span> that significantly updated the Commission's fiscal year (FY) 2018 fee <span class=\"match\">schedule</span> (last fee <span class=\"match\">schedule</span> before implementation of the RAY BAUM'S Act). Accordingly, in 2022, pursuant to <span class=\"match\">section</span> 8(b) of the Act, the Commission adjusted the fees by applying an inflation factor to the fees adopted in 2020 to reflect a change \n \n in the CPI of 11.59%, an increase of 30.958"},{"title":"Schedules of Controlled Substances: Placement of MDMB-4en-PINACA in Schedule I","type":"Proposed Rule","abstract":"The Drug Enforcement Administration proposes placing methyl 3,3-dimethyl-2-(1-(pent-4-en-1-yl)-1H-indazole-3-carboxamido)butanoate (other name: MDMB-4en-PINACA), including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle MDMB-4en-PINACA.","document_number":"2025-19348","html_url":"https://www.federalregister.gov/documents/2025/10/02/2025-19348/schedules-of-controlled-substances-placement-of-mdmb-4en-pinaca-in-schedule-i","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-10-02/pdf/2025-19348.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-19348.pdf?1759322729","publication_date":"2025-10-02","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"between the <span class=\"match\">schedules</span> of substances in the 1971 Convention and the CSA. The CSA has five <span class=\"match\">schedules</span> (<span class=\"match\">schedules</span> I-V) with specific criteria set forth for each <span class=\"match\">schedule</span>. <span class=\"match\">Schedule</span> I is the only possible <span class=\"match\">schedule</span> in which a drug or other substance may be placed if it has high potential for abuse and no currently accepted medical use in treatment in the United States.\n 7 \n \n In contrast, the 1971 Convention has four <span class=\"match\">schedules</span> (<span class=\"match\">Schedules</span> I-IV) but does not have specific criteria for each <span class=\"match\">schedule</span>. The 1971 Convention simply defines its four <span class=\"match\">schedules</span>, in Article"},{"title":"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction","type":"Rule","abstract":"This document corrects typographical and technical errors in the final rule that appeared in the November 5, 2025 Federal Register titled \"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program\" (hereinafter referred to as the CY 2026 PFS final rule), specifying finalized changes to the Medicare physician fee schedule (PFS) that is applicable for calendar year (CY) 2026, and other changes to Medicare Part B payment policies.","document_number":"2026-04797","html_url":"https://www.federalregister.gov/documents/2026/03/12/2026-04797/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-03-12/pdf/2026-04797.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-04797.pdf?1773233110","publication_date":"2026-03-12","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"first full paragraph, line 23, the reference “<span class=\"match\">section</span> VII.I.5.” is corrected to read “<span class=\"match\">section</span> VI.F.4.”. \n 77. On page 49970, third column, first partial paragraph, line 4, the reference “<span class=\"match\">section</span> VI.E.7.b.(1).” is corrected to read “<span class=\"match\">section</span> VI.F.4.b”. \n 78. On page 49971, \n \n a. Second column, fourth full paragraph, line 1, the reference “<span class=\"match\">section</span> \n \n VI.H” is corrected to read “<span class=\"match\">section</span> VI.B.”.\n \n b. Third column, second full paragraph, line 1, the reference “<span class=\"match\">section</span> VI.E.b.(1).” is corrected to read “<span class=\"match\">section</span> VI.F.4.b.”. \n 79. On page 49973, third column"},{"title":"Certain Cameras, Camera Systems, and Accessories Used Therewith; Notice of Commission Determination To Review in Part a Final Initial Determination of Violation of Section 337; Schedule for Filing Written Submissions on Certain Issues Under Review and on Remedy, the Public Interest, and Bonding","type":"Notice","abstract":"Notice is hereby given that the U.S. International Trade Commission has determined to review in part a final initial determination (\"Final ID\") issued by the presiding administrative law judge (\"ALJ\") finding a violation of section 337 of the Tariff Act of 1930. The Commission requests briefing from the parties on certain issues under review and from the parties, interested government agencies, and interested persons on remedy, the public interest, and bonding based on the schedule set forth below.","document_number":"2025-17827","html_url":"https://www.federalregister.gov/documents/2025/09/16/2025-17827/certain-cameras-camera-systems-and-accessories-used-therewith-notice-of-commission-determination-to","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-09-16/pdf/2025-17827.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-17827.pdf?1757940312","publication_date":"2025-09-16","agencies":[{"raw_name":"INTERNATIONAL TRADE COMMISSION","name":"International Trade Commission","id":262,"url":"https://www.federalregister.gov/agencies/international-trade-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/262","parent_id":null,"slug":"international-trade-commission"}],"excerpts":"existing evidentiary record, and the parties' submissions during the investigation. \n 1. Relying on the existing evidentiary record and the applicable law, <span class=\"match\">please</span> explain in detail whether the accused products infringe the D'435 patent. As a part of that explanation, <span class=\"match\">please</span> explain the legal significance of the accused products' pivoting rear screen and its ability to be in multiple positions. <span class=\"match\">Please</span> explain how your reply to this question relates to the arguments made before the ALJ. \n In answering the above briefing question, the parties should specifically"},{"title":"Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I","type":"Proposed Rule","abstract":"The Drug Enforcement Administration proposes placing the substance 4-fluoroamphetamine (4-FA; 1-(4-fluorophenyl)propan-2-amine), including its salts, isomers, and salts of isomers, in schedule I of the Controlled Substances Act. This action is being taken, in part, to enable the United States to meet its obligations under the 1971 Convention on Psychotropic Substances. If finalized, this action would impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis with, or possess) or propose to handle 4-fluoroamphetamine.","document_number":"2025-09988","html_url":"https://www.federalregister.gov/documents/2025/06/03/2025-09988/schedules-of-controlled-substances-placement-of-4-fluoroamphetamine-in-schedule-i","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-06-03/pdf/2025-09988.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-09988.pdf?1748868312","publication_date":"2025-06-03","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"between the <span class=\"match\">schedules</span> of substances in the 1971 Convention and the CSA. The CSA has five <span class=\"match\">schedules</span> (<span class=\"match\">schedules</span> I-V) with specific criteria set forth for each <span class=\"match\">schedule</span>. <span class=\"match\">Schedule</span> I is the only possible <span class=\"match\">schedule</span> in which a drug or other substance may be placed if it has high potential for abuse and no currently accepted medical use in treatment in the United States.\n 7 \n \n In contrast, the 1971 Convention has four <span class=\"match\">schedules</span> (<span class=\"match\">Schedules</span> I-IV) but does not have specific criteria for each <span class=\"match\">schedule</span>. The 1971 Convention simply defines its four <span class=\"match\">schedules</span>, in Article"},{"title":"Schedules of Controlled Substances: Placement of Three Specific Fentanyl-Related Substances in Schedule I","type":"Proposed Rule","abstract":"The Drug Enforcement Administration proposes placing three fentanyl-related substances, as identified in this proposed rule, in schedule I of the Controlled Substances Act. These three substances fall within the definition of fentanyl-related substances set forth in the February 6, 2018 temporary scheduling order. Through the Temporary Reauthorization and Study of Emergency Scheduling of Fentanyl Analogues Act, which became law on February 6, 2020, Congress extended the temporary control of fentanyl-related substances until May 6, 2021. This temporary order was subsequently extended multiple times, most recently on March 15, 2025, which extended the order until September 30, 2025. If finalized, this action would make permanent the existing regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess), or propose to handle these three specific controlled substances.","document_number":"2025-10372","html_url":"https://www.federalregister.gov/documents/2025/06/10/2025-10372/schedules-of-controlled-substances-placement-of-three-specific-fentanyl-related-substances-in","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-06-10/pdf/2025-10372.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-10372.pdf?1749473109","publication_date":"2025-06-10","agencies":[{"raw_name":"DEPARTMENT OF JUSTICE","name":"Justice Department","id":268,"url":"https://www.federalregister.gov/agencies/justice-department","json_url":"https://www.federalregister.gov/api/v1/agencies/268","parent_id":null,"slug":"justice-department"},{"raw_name":"Drug Enforcement Administration","name":"Drug Enforcement Administration","id":116,"url":"https://www.federalregister.gov/agencies/drug-enforcement-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/116","parent_id":268,"slug":"drug-enforcement-administration"}],"excerpts":"\n para \n -fluoroacetyl fentanyl, and \n para \n -methyl acetyl fentanyl. As such, DEA proposes to permanently <span class=\"match\">schedule</span> these three substances as controlled substances under the CSA.\n \n Proposed Determination of Appropriate <span class=\"match\">Schedule</span> \n \n The CSA establishes five <span class=\"match\">schedules</span> of controlled substances known as <span class=\"match\">schedules</span> I, II, III, IV, and V. The CSA also outlines the findings required to place a drug or other substance in any particular <span class=\"match\">schedule</span>.\n 25 \n \n After consideration of the analysis and \n \n recommendation of the Assistant Secretary for HHS and review"},{"title":"Monthly Notices: Applications and Amendments to Licenses Involving No Significant Hazards Considerations; Revised Schedule and Title Change","type":"Notice","abstract":"The U.S. Nuclear Regulatory Commission (NRC) is notifying the public of its revised schedule and title change for Monthly Notices of Applications and Amendments to Facility Operating Licenses and Combined Licenses Involving No Significant Hazards Considerations.","document_number":"2026-08346","html_url":"https://www.federalregister.gov/documents/2026/04/29/2026-08346/monthly-notices-applications-and-amendments-to-licenses-involving-no-significant-hazards","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-29/pdf/2026-08346.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-08346.pdf?1777380323","publication_date":"2026-04-29","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"ACTION: \n Notice. \n \n \n SUMMARY: \n The U.S. Nuclear Regulatory Commission (NRC) is notifying the public of its revised <span class=\"match\">schedule</span> and title change for Monthly Notices of Applications and Amendments to Facility Operating Licenses and Combined Licenses Involving No Significant Hazards Considerations. \n \n \n DATES: \n The revised <span class=\"match\">schedule</span> and title change described in this document takes effect on May 12, 2026. \n \n \n ADDRESSES: \n <span class=\"match\">Please</span> <span class=\"match\">refer</span> to Docket ID NRC-2026-2113 when contacting the NRC about the availability of information regarding this document. You"},{"title":"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction","type":"Proposed Rule","abstract":"This document corrects typographical and technical errors in the proposed rule that appeared in the July 16, 2025 Federal Register (90 FR 32352) titled \"Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program\" (hereinafter referred to as the CY 2026 PFS proposed rule), specifying proposed changes to the Medicare physician fee schedule (PFS) that is applicable for calendar year (CY) 2026, and other changes to Medicare Part B payment policies, as well as proposals regarding other Medicare payment policies.","document_number":"2025-15492","html_url":"https://www.federalregister.gov/documents/2025/08/14/2025-15492/medicare-and-medicaid-programs-cy-2026-payment-policies-under-the-physician-fee-schedule-and-other","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-14/pdf/2025-15492.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-15492.pdf?1755089135","publication_date":"2025-08-14","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Centers for Medicare & Medicaid Services","name":"Centers for Medicare & Medicaid Services","id":45,"url":"https://www.federalregister.gov/agencies/centers-for-medicare-medicaid-services","json_url":"https://www.federalregister.gov/api/v1/agencies/45","parent_id":221,"slug":"centers-for-medicare-medicaid-services"}],"excerpts":"accordance with § 414.1325 that has a benchmark at paragraph (b)(1)(ii) of this <span class=\"match\">section</span>, meets the case minimum requirement at paragraph (b)(1)(iii) of this <span class=\"match\">section</span>, and meets the data completeness requirement at § 414.1340 and for each administrative claims-based measure that has a benchmark at paragraph (b)(1)(ii) of this <span class=\"match\">section</span> and meets the case minimum requirement at paragraph (b)(1)(iii) of this <span class=\"match\">section</span>. Except as provided under paragraph (b)(1)(i)(C) of this <span class=\"match\">section</span>, beginning with the CY 2023 performance period/2025 MIPS payment year, MIPS"},{"title":"Oleoresin Paprika From India; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations","type":"Notice","abstract":"The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-771 and 731-TA-1755 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of oleoresin paprika from India, provided for in subheadings 3203.00.80 and 3301.90.10 of the Harmonized Tariff Schedule of the United States, preliminarily determined by the Department of Commerce (\"Commerce\") to be subsidized and sold at less-than-fair-value.","document_number":"2026-07611","html_url":"https://www.federalregister.gov/documents/2026/04/20/2026-07611/oleoresin-paprika-from-india-scheduling-of-the-final-phase-of-countervailing-duty-and-antidumping","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-20/pdf/2026-07611.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-07611.pdf?1776429912","publication_date":"2026-04-20","agencies":[{"raw_name":"INTERNATIONAL TRADE COMMISSION","name":"International Trade Commission","id":262,"url":"https://www.federalregister.gov/agencies/international-trade-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/262","parent_id":null,"slug":"international-trade-commission"}],"excerpts":"and the E number is E160c. Subject oleoresin paprika may also be <span class=\"match\">referred</span> to by other product names, including, but not limited to, paprika oleoresin, oleoresin of paprika, paprika extract, extract of paprika, paprika oil, or paprika essential oil.\n 1 \n \n \n \n \n 1 \n  For the complete scope of these investigations, <span class=\"match\">please</span> see 91 FR 5427 (February 6, 2026) and 91 FR 16636 (April 2, 2026)\n \n \n \n Background. \n —The final phase of these investigations is being <span class=\"match\">scheduled</span> pursuant to <span class=\"match\">sections</span> 705(b) and 731(b) of the Tariff Act of 1930 (19 U.S.C. 1671d(b)"},{"title":"Jurisdictional Separations and Referral to the Federal-State Joint Board","type":"Rule","abstract":"In this document, the Federal Communications Commission (Commission) extends, for up to an additional six years, the freeze of the jurisdictional separations category relationships and cost allocation factors (together, separations rules) for rate-of-return incumbent local exchange carriers (LECs). Further extending the freeze, which is set to expire on December 31, 2024, will enable the Commission to continue to work with the Federal-State Joint Board on Jurisdictional Separations (Joint Board) to determine the future of these rules. The Commission declines to provide carriers an opportunity to unfreeze their current category relationships and refers to the Joint Board to consider whether comprehensive reform is needed at this time or if the Commission should allow these rules to become obsolete over time and whether a permanent freeze is warranted, and if so, whether carriers still using separations should be given the chance to unfreeze their category relationships every few years.","document_number":"2024-27480","html_url":"https://www.federalregister.gov/documents/2024/11/25/2024-27480/jurisdictional-separations-and-referral-to-the-federal-state-joint-board","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2024-11-25/pdf/2024-27480.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2024-27480.pdf?1732283123","publication_date":"2024-11-25","agencies":[{"raw_name":"FEDERAL COMMUNICATIONS COMMISSION","name":"Federal Communications Commission","id":161,"url":"https://www.federalregister.gov/agencies/federal-communications-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/161","parent_id":null,"slug":"federal-communications-commission"}],"excerpts":"the following <span class=\"match\">sections</span>, remove the date “December 31, 2024” and add in its place the date “December 31, 2030” wherever it appears: \n a. <span class=\"match\">Section</span> 36.3(a) through (c), (d) introductory text, and (e); \n b. <span class=\"match\">Section</span> 36.123(a)(5) and (6); \n c. <span class=\"match\">Section</span> 36.124(c) and (d); \n d. <span class=\"match\">Section</span> 36.125(h) and (i); \n e. <span class=\"match\">Section</span> 36.126(b)(5) and (6), (c)(4), (e)(4), and (f)(2); \n f. <span class=\"match\">Section</span> 36.141(c); \n g. <span class=\"match\">Section</span> 36.142(c); \n h. <span class=\"match\">Section</span> 36.152(d); \n i. <span class=\"match\">Section</span> 36.154(g); \n j. <span class=\"match\">Section</span> 36.155(b); \n k. <span class=\"match\">Section</span> 36.156(c); \n l. <span class=\"match\">Section</span> 36.157(b); \n m. <span class=\"match\">Section</span> 36.191(d); \n"},{"title":"Fee Schedules; Fee Recovery for Fiscal Year 2025","type":"Rule","abstract":"The U.S. Nuclear Regulatory Commission (NRC) is correcting a final rule that was published in the Federal Register on June 24, 2025, regarding the amendment of licensing, inspection, special project, and annual fees charged to NRC's applicants and licensees. This action is necessary to correct a typo to the dollar amount in the schedule of materials annual fees and fees for Government agencies licensed by the NRC.","document_number":"2025-14147","html_url":"https://www.federalregister.gov/documents/2025/07/28/2025-14147/fee-schedules-fee-recovery-for-fiscal-year-2025","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-07-28/pdf/2025-14147.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14147.pdf?1753447513","publication_date":"2025-07-28","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"amendment of licensing, inspection, special project, and annual fees charged to NRC's applicants and licensees. This action is necessary to correct a typo to the dollar amount in the <span class=\"match\">schedule</span> of materials annual fees and fees for Government agencies licensed by the NRC.\n \n \n \n DATES: \n The correction takes effect on August 25, 2025. \n \n \n ADDRESSES: \n <span class=\"match\">Please</span> <span class=\"match\">refer</span> to Docket ID NRC-2023-0069 when contacting the NRC about the availability of information for this action. You may obtain publicly available information related to this action by any of"},{"title":"Chromium Trioxide From India and Turkey; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations","type":"Notice","abstract":"The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-779 and 731-TA-1765-1766 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of chromium trioxide from India and Turkey, provided for in subheading 2819.10.00 of the Harmonized Tariff Schedule of the United States, preliminarily determined by the Department of Commerce (\"Commerce\") to be sold at less-than-fair- value and by reason of imports of chromium trioxide from India preliminarily determined by Commerce to be subsidized by the government of India.","document_number":"2026-11368","html_url":"https://www.federalregister.gov/documents/2026/06/08/2026-11368/chromium-trioxide-from-india-and-turkey-scheduling-of-the-final-phase-of-countervailing-duty-and","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-08/pdf/2026-11368.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-11368.pdf?1780663507","publication_date":"2026-06-08","agencies":[{"raw_name":"INTERNATIONAL TRADE COMMISSION","name":"International Trade Commission","id":262,"url":"https://www.federalregister.gov/agencies/international-trade-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/262","parent_id":null,"slug":"international-trade-commission"}],"excerpts":"inorganic compound with the molecular formula CrO\n 3 \n in dry form and H\n 2 \n CrO\n 4 \n in solution form. All relevant formulas <span class=\"match\">refer</span> to same product with one unit of Chromium (as Cr+6) and three units of Oxygen, such as Cr\n 4 \n O\n 12 \n ; and Cr\n 0.25 \n O\n 0.75 \n .\n \n The product in dry form is generally <span class=\"match\">referred</span> to as chromium trioxide, which is the acidic anhydride of chromic acid. Chromium trioxide in solution form may be <span class=\"match\">referred</span> to as chromic acid. However, the dry form may also be marketed under the name chromic acid. \n A non-exhaustive list of other"},{"title":"Information Collection: Scheduling Information for the Licensing of Accident Tolerant, Higher Burnup, and Increased Enrichment Fuels","type":"Notice","abstract":"The U.S. Nuclear Regulatory Commission (NRC) invites public comment on the renewal of Office of Management and Budget (OMB) approval for an existing collection of information. The information collection is entitled, \"Scheduling Information for the Licensing of Accident Tolerant, Higher Burnup, and Increased Enrichment Fuels.\"","document_number":"2025-22422","html_url":"https://www.federalregister.gov/documents/2025/12/10/2025-22422/information-collection-scheduling-information-for-the-licensing-of-accident-tolerant-higher-burnup","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-12-10/pdf/2025-22422.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-22422.pdf?1765287912","publication_date":"2025-12-10","agencies":[{"raw_name":"NUCLEAR REGULATORY COMMISSION","name":"Nuclear Regulatory Commission","id":383,"url":"https://www.federalregister.gov/agencies/nuclear-regulatory-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/383","parent_id":null,"slug":"nuclear-regulatory-commission"}],"excerpts":"technical questions, contact the individual(s) listed in the \n FOR FURTHER INFORMATION CONTACT \n <span class=\"match\">section</span> of this document.\n \n \n • \n Mail comments to: \n Heather Dempsey, Office of the Chief Information Officer, Mail Stop: T-6 A10M, U.S. Nuclear Regulatory Commission, Washington, DC 20555-0001.\n \n \n For additional direction on obtaining information and submitting comments, see “Obtaining Information and Submitting Comments” in the \n SUPPLEMENTARY INFORMATION \n <span class=\"match\">section</span> of this document.\n \n \n \n FOR FURTHER INFORMATION CONTACT: \n \n Heather Dempsey, Office of"},{"title":"L-Lysine From China; Scheduling of the Final Phase of Countervailing Duty and Antidumping Duty Investigations","type":"Notice","abstract":"The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-767 and 731-TA-1750 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of animal feed-grade l-lysine from China, provided for in subheading 2922.41.00 of the Harmonized Tariff Schedule of the United States, preliminarily determined by the Department of Commerce (\"Commerce\") to be subsidized and sold at less-than-fair-value.","document_number":"2026-06529","html_url":"https://www.federalregister.gov/documents/2026/04/03/2026-06529/l-lysine-from-china-scheduling-of-the-final-phase-of-countervailing-duty-and-antidumping-duty","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-04-03/pdf/2026-06529.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-06529.pdf?1775133915","publication_date":"2026-04-03","agencies":[{"raw_name":"INTERNATIONAL TRADE COMMISSION","name":"International Trade Commission","id":262,"url":"https://www.federalregister.gov/agencies/international-trade-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/262","parent_id":null,"slug":"international-trade-commission"}],"excerpts":"Commission hereby gives notice of the <span class=\"match\">scheduling</span> of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-767 and 731-TA-1750 (Final) pursuant to the Tariff Act of 1930 to determine whether an industry in the United States is materially injured or threatened with material injury, or the establishment of an industry in the United States is materially retarded, by reason of imports of animal feed-grade l-lysine from China, provided for in subheading 2922.41.00 of the Harmonized Tariff <span class=\"match\">Schedule</span> of the United States, preliminarily"},{"title":"Information Collection; General Services Administration Acquisition Regulation; Federal Supply Schedule Pricing Disclosures and Sales Reporting","type":"Notice","abstract":"Under the provisions of the Paperwork Reduction Act, the Regulatory Secretariat Division is submitting a request to the Office of Management and Budget (OMB) to review and approve an extension of a previously approved information collection requirement regarding OMB Control No. 3090-0235, Federal Supply Schedule Pricing Disclosures and Sales Reporting.","document_number":"2025-19118","html_url":"https://www.federalregister.gov/documents/2025/10/01/2025-19118/information-collection-general-services-administration-acquisition-regulation-federal-supply","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-10-01/pdf/2025-19118.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-19118.pdf?1759236312","publication_date":"2025-10-01","agencies":[{"raw_name":"GENERAL SERVICES ADMINISTRATION","name":"General Services Administration","id":210,"url":"https://www.federalregister.gov/agencies/general-services-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/210","parent_id":null,"slug":"general-services-administration"}],"excerpts":"name, company name (if any), and “Information Collection 3090-0235, Federal Supply <span class=\"match\">Schedule</span> Pricing Disclosures and Sales Reporting” on your attached document. If your comment cannot be submitted using \n regulations.gov, \n call or email the points of contact in the \n FOR FURTHER INFORMATION CONTACT \n <span class=\"match\">section</span> of this document for alternate instructions.\n \n \n Instructions: \n <span class=\"match\">Please</span> submit comments only and cite information collection “3090-0235, Federal Supply <span class=\"match\">Schedule</span> Pricing Disclosures and Sales Reporting” in all correspondence related to this collection"},{"title":"Assessments Thresholds, Rate Schedules, and Adjustments","type":"Proposed Rule","abstract":"The Federal Deposit Insurance Corporation (FDIC) invites public comment on a proposed rule that would amend the assessment regulations in 12 CFR part 327 to: update the $10 billion asset threshold in the definitions of small and large institutions to $30 billion and adjust the threshold every four years to reflect inflation, pursuant to a pre-determined indexing methodology; decrease initial base deposit insurance assessment rate schedules by 2 basis points for small institutions and by 1 basis point for large and highly complex institutions; provide a downward resolution readiness adjustment to assessment rates for large and highly complex institutions, including 0.5 basis points for passing virtual data room testing and 0.5 basis points for providing prescribed data access; and remove obsolete provisions.","document_number":"2026-13192","html_url":"https://www.federalregister.gov/documents/2026/06/30/2026-13192/assessments-thresholds-rate-schedules-and-adjustments","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-06-30/pdf/2026-13192.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-13192.pdf?1782737120","publication_date":"2026-06-30","agencies":[{"raw_name":"FEDERAL DEPOSIT INSURANCE CORPORATION","name":"Federal Deposit Insurance Corporation","id":164,"url":"https://www.federalregister.gov/agencies/federal-deposit-insurance-corporation","json_url":"https://www.federalregister.gov/api/v1/agencies/164","parent_id":null,"slug":"federal-deposit-insurance-corporation"}],"excerpts":"assessment rate <span class=\"match\">schedules</span> provided for in paragraph (a) of this <span class=\"match\">section</span>.\n \n \n (ii) \n Assessment rate <span class=\"match\">schedules</span> for new large and highly complex institutions beginning [the quarter \n in which a final rule becomes effective] \n and for all subsequent periods. \n Beginning in [the quarter in which a final rule becomes effective] and for all subsequent assessment periods, new large and new highly complex institutions shall be subject to the initial and total base assessment rate <span class=\"match\">schedules</span> provided for in paragraph (b) of this <span class=\"match\">section</span>.\n \n \n (iii) \n Assessment"},{"title":"Public Meeting of the National Sea Grant Advisory Board","type":"Notice","abstract":"This notice sets forth the schedule and proposed agenda of a forthcoming meeting of the National Sea Grant Advisory Board (Board), a Federal Advisory Committee. Board members will discuss and provide advice on the National Sea Grant College Program (Sea Grant) in the areas of program evaluation, strategic planning, education and extension, science and technology programs, and other matters as described in the agenda found on the Sea Grant website. For more information on this Federal Advisory Committee please visit the Federal Advisory Committee database: https://www.facadatabase.gov/FACA/ FACAPublicPage.","document_number":"2026-02103","html_url":"https://www.federalregister.gov/documents/2026/02/03/2026-02103/public-meeting-of-the-national-sea-grant-advisory-board","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2026-02-03/pdf/2026-02103.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2026-02103.pdf?1770039915","publication_date":"2026-02-03","agencies":[{"raw_name":"DEPARTMENT OF COMMERCE","name":"Commerce Department","id":54,"url":"https://www.federalregister.gov/agencies/commerce-department","json_url":"https://www.federalregister.gov/api/v1/agencies/54","parent_id":null,"slug":"commerce-department"},{"raw_name":"National Oceanic and Atmospheric Administration","name":"National Oceanic and Atmospheric Administration","id":361,"url":"https://www.federalregister.gov/agencies/national-oceanic-and-atmospheric-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/361","parent_id":54,"slug":"national-oceanic-and-atmospheric-administration"}],"excerpts":"\n DATES: \n The announced meeting is <span class=\"match\">scheduled</span> for Tuesday February 24, 2026 from 3:00 p.m.-6:00 p.m. (EST), Wednesday February 25, 2026 from 3:00 p.m.-6:00 p.m. (EST) and Thursday February 26, 2026 from 3:00 p.m.-6:00 p.m. (EST). \n \n \n ADDRESSES: \n The meeting will be held virtually. Registration is not required. For more information about the virtual meeting see below in the “For Further Information Contact” <span class=\"match\">section</span>. \n \n \n FOR FURTHER INFORMATION CONTACT: \n \n For any questions concerning the meeting, <span class=\"match\">please</span> contact Ms. Susan Holmes, National Sea"},{"title":"Erythritol From China; Scheduling of the Final Phase of Antidumping and Countervailing Duty Investigations","type":"Notice","abstract":"The Commission hereby gives notice of the scheduling of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-751 and 731-TA-1729 (Final) pursuant to the Tariff Act of 1930 (\"the Act\") to determine whether an industry in the United States is materially injured or threatened with material injury, by reason of imports of erythritol from China, provided for in subheading 2905.49.40 of the Harmonized Tariff Schedule of the United States, preliminarily determined by the Department of Commerce (\"Commerce\") to be subsidized by the government of China and sold at less-than-fair- value.","document_number":"2025-14592","html_url":"https://www.federalregister.gov/documents/2025/08/01/2025-14592/erythritol-from-china-scheduling-of-the-final-phase-of-antidumping-and-countervailing-duty","pdf_url":"https://www.govinfo.gov/content/pkg/FR-2025-08-01/pdf/2025-14592.pdf","public_inspection_pdf_url":"https://public-inspection.federalregister.gov/2025-14592.pdf?1753965916","publication_date":"2025-08-01","agencies":[{"raw_name":"INTERNATIONAL TRADE COMMISSION","name":"International Trade Commission","id":262,"url":"https://www.federalregister.gov/agencies/international-trade-commission","json_url":"https://www.federalregister.gov/api/v1/agencies/262","parent_id":null,"slug":"international-trade-commission"}],"excerpts":"ACTION: \n Notice. \n \n \n SUMMARY: \n \n The Commission hereby gives notice of the <span class=\"match\">scheduling</span> of the final phase of antidumping and countervailing duty investigation Nos. 701-TA-751 and 731-TA-1729 (Final) pursuant to the Tariff Act of 1930 (“the Act”) to determine whether an industry in the United States is materially injured or threatened with material injury, by reason of imports of erythritol from China, provided for in subheading 2905.49.40 of the Harmonized Tariff <span class=\"match\">Schedule</span> of the United States, preliminarily determined by the Department of Commerce"}]}